Zendal logo

ContactoAccionistas
ES / EN
Zendal LinkedinZendal YoutubeZendal Twitter
GrupoSalud humanaSalud animalCDMO ServicesPremiosPersonasPrensa
  • Zendal
    • El Grupo Zendal
    • Isabel Zendal
    • One Health
    • Conocimiento
  • Salud humana
  • Salud animal
  • Servicios CDMO
  • Premios Zendal
  • Talento
  • Prensa
  • Contacto
  • Accionistas
  • English
  • Zendal Linkedin
  • Zendal Youtube
  • Zendal Twitter
El Grupo Zendal
Isabel Zendal
One Health
Conocimiento
CZ Vaccines
Biofabri
Vetia
Petia
Zinereo
Probisearch
Zendal Portugal
Biofarmacéuticos
Salud humana
Salud animal
Edición 2025
Inscríbete aquí
Bases
Empleo
Movimiento Z
NOTICIA
05 · 06 · 2025
The Sixth Edition of the International Zendal Awards is Now Open for Applications
Contacto de prensa
  • Teléfono (+34) 986 330 400
  • b.diaz@zendal.com
05 · 06 · 2025The Sixth Edition of the International Zendal Awards is Now Open for Applications
LEER MÁS
18 · 03 · 2025ZENDAL receives EMA recommendation for its vaccine against EHD
LEER MÁS
27 · 02 · 2025Biofabri and IAVI announce first vaccinations in the IMAGINE clinical trial, a large-scale safety and efficacy trial of the tuberculosis vaccine candidate MTBVAC
LEER MÁS
21 · 01 · 2025Zendal supplied 42 million doses of bluetongue vaccine in Europe during 2024.
LEER MÁS
12 · 11 · 2024The Zendal Group Honors Human and Animal Health Innovators at its Fifth Annual Awards Gala
LEER MÁS
24 · 10 · 2024Early detection of Alzheimer’s disease and the development of vaccines against ticks in cattle are the objectives of the projects that won the Zendal Prize.
LEER MÁS
05 · 07 · 2024Zendal launches first vaccine against Epizootic Haemorrhagic Disease (EHD) in Spain
LEER MÁS
28 · 06 · 2024Zendal Group launches the 5th edition of its International Zendal Awards for human and animal health projects
LEER MÁS
20 · 06 · 2024Biofabri and TBVI sign a contract with the European Health and Digital Executive Agency to accelerate the final development of the new TB vaccine MTBVAC
LEER MÁS
23 · 03 · 2024MTBVAC, the first vaccine against Tuberculosis derived from a human source, begins clinical trials in adults in India.
LEER MÁS
18 · 03 · 2024ZENDAL launches the first DNA technology vaccine against canine leishmaniasis
LEER MÁS
24 · 01 · 2024VETIA ANIMAL HEALTH STRENGTHENS ITS PORTFOLIO
LEER MÁS
  • 1
  • 2
  • 3
Logo Cz Vaccines
Logo Cz Vaccines
Logo Biofabri
Logo Vetia
Logo Petia
Logo ProbiSearch
Logo Zinereo
Logo Ovejero
Logo Maymo
A Relva s/n. 36410, O Porriño. Pontevedra (Spain)
+34 986 330 400
Zendal LinkedinZendal YoutubeZendal Twitter
BiotecnologíaSalud humanaSalud animalPrensaContactoAviso legalPolítica de privacidadPolítica de cookiesSeguridad ambiental